The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA

被引：0
|
作者：
Katherine Fleshner
Sigrid V. Carlsson
Monique J. Roobol
机构：
[1] Schulich School of Medicine and Dentistry,Department of Surgery and Department of Epidemiology and Biostatistics
[2] University of Western Ontario,Department of Urology
[3] Memorial Sloan Kettering Cancer Center,Department of Urology
[4] Institute of Clinical Sciences,undefined
[5] Sahlgrenska Academy at the University of Gothenburg,undefined
[6] Erasmus Medical Center,undefined
来源：
Nature Reviews Urology | 2017年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In 2012, the United States Preventive Services Task Force (USPSTF) issued a Grade D (against screening) recommendation for PSA screening for prostate cancerRates of PSA screening, prostate biopsy and overall prostate cancer incidence declined in the first few years after the recommendation, with a shift towards higher grade and stage of prostate tumours at the time of detectionDespite the recommendation, some physicians report ongoing willingness to screen appropriately selected men, and many men report that they intend to continue to ask for the PSA test from their doctorIncreased follow-up durations are needed in order to understand whether the decreased rates of PSA screening will effect prostate cancer metastasis and mortality
引用
收藏
页码：26 / 37
页数：11
相关论文
共 50 条
  • [1] The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA
    Fleshner, Katherine
    Carlsson, Sigrid V.
    Roobol, Monique J.
    NATURE REVIEWS UROLOGY, 2017, 14 (01) : 26 - 37
  • [2] Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
    Jemal, Ahmedin
    Fedewa, Stacey A.
    Ma, Jiemin
    Siegel, Rebecca
    Lin, Chun Chieh
    Brawley, Otis
    Ward, Elizabeth M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (19): : 2054 - 2061
  • [3] Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
    Lucca, Ilaria
    Shariar, Shahrokh F.
    EUROPEAN UROLOGY, 2016, 70 (01) : 205 - 206
  • [4] PROSTATE CANCER SURVIVORS OPPOSED TO USPSTF RECOMMENDATION AGAINST PSA SCREENING
    Orom, Heather
    Homish, D. Lynn
    Underwood, WIllie
    Kiviniemi, Marc T.
    Homish, Gregory G.
    Nelson, Christian J.
    ANNALS OF BEHAVIORAL MEDICINE, 2014, 47 : S101 - S101
  • [5] THE EFFECT OF THE 2012 USPSTF ON PSA FOR PROSTATE CANCER SCREENING
    Stein, Barry
    Smith, Cynthia
    Feustel, Paul
    JOURNAL OF UROLOGY, 2018, 199 (04): : E764 - E764
  • [6] PSA SCREENING, PROSTATE BIOPSY, AND TREATMENT OF PROSTATE CANCER IN THE YEARS SURROUNDING THE USPSTF RECOMMENDATION AGAINST PROSTATE CANCER SCREENING
    Kearns, James
    Holt, Sarah
    Wright, Jonathan
    Lin, Daniel
    Lange, Paul
    Gore, Jonathan
    JOURNAL OF UROLOGY, 2017, 197 (04): : E822 - E823
  • [7] PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening
    Kearns, James T.
    Holt, Sarah K.
    Wright, Jonathan L.
    Lin, Daniel W.
    Lange, Paul H.
    Gore, John L.
    CANCER, 2018, 124 (13) : 2733 - 2739
  • [8] Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation
    Kensler, Kevin H.
    Pernar, Claire H.
    Mahal, Brandon A.
    Nguyen, Paul L.
    Trinh, Quoc-Dien
    Kibel, Adam S.
    Rebbeck, Timothy R.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (06): : 719 - 726
  • [9] Trends in histology of newly diagnosed prostate cancer subsequent to USPSTF PSA screening recommendation.
    Olsson, Carl A.
    Anderson, Ann E.
    Kapoor, Deepak A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [10] CHANGES IN PSA SCREENING RELATIVE TO THE REVISED USPSTF GUIDANCE FOR PROSTATE CANCER SCREENING
    Leapman, Michael
    Wang, Rong
    Gross, Cary
    Ma, Xiaomei
    JOURNAL OF UROLOGY, 2021, 206 : E856 - E856
12345